DK1480646T3 - Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde - Google Patents
Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfældeInfo
- Publication number
- DK1480646T3 DK1480646T3 DK03714776T DK03714776T DK1480646T3 DK 1480646 T3 DK1480646 T3 DK 1480646T3 DK 03714776 T DK03714776 T DK 03714776T DK 03714776 T DK03714776 T DK 03714776T DK 1480646 T3 DK1480646 T3 DK 1480646T3
- Authority
- DK
- Denmark
- Prior art keywords
- infectives
- immunomodulators
- preventive therapy
- acute stroke
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10210536 | 2002-03-05 | ||
DE10218328A DE10218328A1 (de) | 2002-03-05 | 2002-04-24 | Mittel zur präventiven Therapie nach akutem Schlaganfall |
PCT/EP2003/002246 WO2003074057A1 (de) | 2002-03-05 | 2003-03-05 | Antiinfektiva und/oder immunnodulatoren zur präventiven therapie nach akutem schlaganfall |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1480646T3 true DK1480646T3 (da) | 2008-11-24 |
Family
ID=27789739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03714776T DK1480646T3 (da) | 2002-03-05 | 2003-03-05 | Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde |
Country Status (15)
Country | Link |
---|---|
US (1) | US8673934B2 (da) |
EP (1) | EP1480646B1 (da) |
JP (1) | JP2005525361A (da) |
CN (1) | CN1652785A (da) |
AT (1) | ATE402702T1 (da) |
AU (1) | AU2003219016B2 (da) |
BR (1) | BRPI0308256A2 (da) |
CA (1) | CA2478133A1 (da) |
DE (2) | DE10218328A1 (da) |
DK (1) | DK1480646T3 (da) |
ES (1) | ES2311093T3 (da) |
MX (1) | MXPA04008573A (da) |
PT (1) | PT1480646E (da) |
RU (1) | RU2327454C2 (da) |
WO (1) | WO2003074057A1 (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005053679A1 (de) * | 2005-06-24 | 2006-12-28 | Bayer Healthcare Ag | Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems |
DE102007020152A1 (de) * | 2007-04-26 | 2008-10-30 | Charité - Universitätsmedizin Berlin | Mittel zur antiinfektiven Behandlung eines Patienten |
WO2009134489A2 (en) * | 2008-02-01 | 2009-11-05 | Albany Medical College | Blockage of interferon-gamma for prevention of polymicrobial synergy |
RU2571282C1 (ru) * | 2014-05-22 | 2015-12-20 | Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства | Способ лечения инсульта |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
CN110964778B (zh) * | 2018-09-29 | 2024-02-23 | 南方医科大学珠江医院 | 肠杆菌科作为缺血性脑卒中生物标志物的用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4437868A1 (de) | 1994-10-22 | 1996-04-25 | Boehringer Ingelheim Int | Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma |
CN1194828A (zh) | 1998-04-22 | 1998-10-07 | 王卫东 | 具有协同作用的美洛西林和舒巴坦的药物组合物 |
DE19937116A1 (de) | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
AU4525801A (en) * | 1999-12-30 | 2001-07-16 | Intermune, Inc | Gamma-ifn liquid-droplet aerosol and method |
-
2002
- 2002-04-24 DE DE10218328A patent/DE10218328A1/de not_active Withdrawn
-
2003
- 2003-03-05 EP EP03714776A patent/EP1480646B1/de not_active Expired - Lifetime
- 2003-03-05 DE DE50310242T patent/DE50310242D1/de not_active Expired - Lifetime
- 2003-03-05 US US10/506,598 patent/US8673934B2/en not_active Expired - Fee Related
- 2003-03-05 CA CA002478133A patent/CA2478133A1/en not_active Abandoned
- 2003-03-05 BR BRPI0308256A patent/BRPI0308256A2/pt not_active IP Right Cessation
- 2003-03-05 MX MXPA04008573A patent/MXPA04008573A/es active IP Right Grant
- 2003-03-05 JP JP2003572574A patent/JP2005525361A/ja active Pending
- 2003-03-05 WO PCT/EP2003/002246 patent/WO2003074057A1/de active IP Right Grant
- 2003-03-05 CN CNA03809150XA patent/CN1652785A/zh active Pending
- 2003-03-05 AT AT03714776T patent/ATE402702T1/de not_active IP Right Cessation
- 2003-03-05 PT PT03714776T patent/PT1480646E/pt unknown
- 2003-03-05 AU AU2003219016A patent/AU2003219016B2/en not_active Ceased
- 2003-03-05 DK DK03714776T patent/DK1480646T3/da active
- 2003-03-05 ES ES03714776T patent/ES2311093T3/es not_active Expired - Lifetime
- 2003-03-05 RU RU2004129591/15A patent/RU2327454C2/ru active
Also Published As
Publication number | Publication date |
---|---|
CA2478133A1 (en) | 2003-09-12 |
DE50310242D1 (de) | 2008-09-11 |
ES2311093T3 (es) | 2009-02-01 |
DE10218328A1 (de) | 2003-09-25 |
PT1480646E (pt) | 2008-11-03 |
ATE402702T1 (de) | 2008-08-15 |
EP1480646B1 (de) | 2008-07-30 |
MXPA04008573A (es) | 2005-09-08 |
WO2003074057A1 (de) | 2003-09-12 |
US20050234089A1 (en) | 2005-10-20 |
WO2003074057A8 (de) | 2005-09-29 |
AU2003219016B2 (en) | 2008-10-16 |
RU2327454C2 (ru) | 2008-06-27 |
AU2003219016A1 (en) | 2003-09-16 |
RU2004129591A (ru) | 2005-09-20 |
CN1652785A (zh) | 2005-08-10 |
EP1480646A1 (de) | 2004-12-01 |
BRPI0308256A2 (pt) | 2016-06-21 |
US8673934B2 (en) | 2014-03-18 |
JP2005525361A (ja) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021012589A (es) | Derivados de piperidina como inhibidores de proteasa especifica de ubiquitina 7. | |
NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
CL2007001996A1 (es) | Compuestos derivados de heteroarilos nitrogenados sustituidos con fenilo, inhibidores de la produccion de citoquinas; composicion farmaceutica que los comprende; y sus usos en el tratamiento del cancer, infecciones, enfermedades inflamatorias y autoinmunes. | |
NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
NO20074807L (no) | Fast farmasoytisk doseringsformulering | |
CL2008001782A1 (es) | Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion. | |
EP3938369A4 (en) | TYK2 INHIBITORS AND USES THEREOF | |
EP3914357A4 (en) | TYK2 INHIBITORS AND THEIR USES | |
BRPI0416268A (pt) | composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla | |
DK1635783T3 (da) | Farmaceutiske præparater omfattende fentanyl til intranasal levering | |
BRPI0508807A (pt) | composição de tratamento capilar, uso de uma composição e método de tratamento de cabelo | |
NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
BR112022021381A2 (pt) | Compostos para o tratamento de sars | |
IL291080A (en) | Systems, methods, and compounds for early and rapid detection of infection by host RNA biomarkers and early detection of covid-19 infection in humans | |
MX2020007777A (es) | Vacunas contra virus de la gripe y usos de las mismas. | |
DK1480646T3 (da) | Antiinfektiva og/eller immunomodulatorer til præventiv terapi efter akut slagtilfælde | |
NO20035328D0 (no) | Nye forbindelser og preparater som katepsinhibitorer | |
NO20062229L (no) | Middel og fremgangsmate for a behandle cancer omfattende strontium, aminosyre(r) og mineralagent(er) | |
NO20043393L (no) | Identifisering av objekter for levering. | |
BRPI0411168A (pt) | composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos | |
ATE412014T1 (de) | Immunmodulatorische konstrukte und deren verwendungen | |
IL309182A (en) | Protease inhibitors for the treatment of corona virus infections | |
IL310209A (en) | ROCK2 inhibitors and their uses | |
BR112022020295A2 (pt) | Compostos para o tratamento de sars |